Roques Elodie, Lessard Martin, Archambault Denis
Department of Biological Sciences, University of Québec at Montréal, Succursale Centre-Ville, P.O. Box 8888, Montreal, QC, H3C 3P8, Canada.
Mol Biotechnol. 2015 Aug;57(8):701-8. doi: 10.1007/s12033-015-9861-6.
The porcine reproductive and respiratory syndrome virus (PRRSV) is an arterivirus of the Arteriviridae family. As the current commercial vaccines are incompletely protective effective against PRRSV infection, we developed a vaccine strategy using replicating but non-disseminating adenovectors (rAdVs) expressing the PRRSV M matrix protein in fusion with the neutralizing major epitope-carrying GP5 envelope protein (Roques et al. in Vet Res 44:17, 2013). Although production of GP5-specific antibodies (Abs) was observed, no PRRSV-specific neutralizing Abs (NAbs) were induced in pigs given the rAdVs expressing M-GP5 or M-GP5m (GP5m being a mutant form of GP5). Nevertheless, partial protection was observed in the M-GP5m-rAdV-inoculated pigs experimentally infected with PRRSV. Here, we determined the impact of the cholera toxin B subunit (CTB, known for its adjuvant effect) in fusion with the C-terminus of M-GP5m on the Ab response to PRRSV. Three-week-old pigs were immunized twice both intramuscularly and intranasally at 3-week intervals with rAdV-expressing the green fluorescent protein (rAdV-GFP), rAdV-M-GP5m, or rAdV-M-GP5m-CTB. Pigs immunized with rAdV-M-GP5m showed a high level of serum GP5-specific Abs (as determined by an indirect ELISA). In contrast, CTB in fusion with M-GP5m had an unexpected severe negative impact on GP5-specific Ab production. PRRSV-specific NAbs could not be detected in any pigs of all groups.
猪繁殖与呼吸综合征病毒(PRRSV)是动脉炎病毒科的一种动脉病毒。由于目前的商业疫苗对PRRSV感染的保护效果不完全,我们开发了一种疫苗策略,使用表达与携带中和主要表位的GP5包膜蛋白融合的PRRSV M基质蛋白的复制但不传播的腺病毒载体(rAdV)(Roques等人,《兽医研究》,2013年,第44卷,第17页)。尽管观察到了GP5特异性抗体(Abs)的产生,但在给予表达M-GP5或M-GP5m(GP5m是GP5的突变形式)的rAdV的猪中未诱导出PRRSV特异性中和抗体(NAbs)。然而,在实验感染PRRSV的M-GP5m-rAdV接种猪中观察到了部分保护作用。在此,我们确定了与M-GP5m的C末端融合的霍乱毒素B亚基(CTB,以其佐剂作用而闻名)对PRRSV抗体反应的影响。3周龄的猪每隔3周分别通过肌肉内和鼻内途径用表达绿色荧光蛋白的rAdV(rAdV-GFP)、rAdV-M-GP5m或rAdV-M-GP5m-CTB免疫两次。用rAdV-M-GP5m免疫的猪表现出高水平的血清GP5特异性抗体(通过间接ELISA测定)。相比之下,与M-GP5m融合的CTB对GP5特异性抗体的产生产生了意想不到的严重负面影响。在所有组的任何猪中均未检测到PRRSV特异性NAbs。